NCT04845438

Brief Summary

MGB is considered to be the best alternative to Roux-en-Y gastric bypass (RYGB) due to the shorter operation time and fewer possible complications. The purpose of this study was to determine biliary reflux in patients undergoing MGB/OAGB with a hand-sewn gastroenteroanastomosis, and MGB/OAGB with a stapler gastroenteroanastomosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
122

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 29, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 10, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 15, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 8, 2022

Completed
Last Updated

April 15, 2021

Status Verified

April 1, 2021

Enrollment Period

10 months

First QC Date

April 10, 2021

Last Update Submit

April 10, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Success

    Determination of the BRI index in patients undergoing MGB/OAGB can be used as a screening method for diagnosing biliary reflux in order to prevent and develop tactic for further management of patients from a risk group of complications associated with the toxic effects of an aggressive bile

    12 month

Study Arms (2)

hand-sewn gastroenteroanastomosis

ACTIVE COMPARATOR
Diagnostic Test: fibrogastroscopy, biopsy of the gastric mucosa, microscopy biopsy materials, using Bile Reflux Index

stapler gastroenteroanastomosis

ACTIVE COMPARATOR
Diagnostic Test: fibrogastroscopy, biopsy of the gastric mucosa, microscopy biopsy materials, using Bile Reflux Index

Interventions

fibrogastroscopy, biopsy of the gastric mucosa, microscopy biopsy materials, using Bile Reflux Index

hand-sewn gastroenteroanastomosisstapler gastroenteroanastomosis

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • morbid obesity
  • BMI above 35 kg/m2 with obesity related comorbidity
  • BMI above 40 kg/m2
  • undergoing MGB/OAGB
  • no bile reflux during preoperative period

You may not qualify if:

  • revisional operations
  • therapy-resistant bile reflux during preoperative period
  • history of bariatric surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Private Healthcare Institution Clinical Hospital "RGD-Medicine" Rostov-on-Don"

Rostov-on-Don, 344010, Russia

RECRUITING

MeSH Terms

Conditions

Stomach UlcerBile Reflux

Condition Hierarchy (Ancestors)

Peptic UlcerDuodenal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesStomach DiseasesBiliary Tract DiseasesDuodenogastric Reflux

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2021

First Posted

April 15, 2021

Study Start

December 29, 2020

Primary Completion

November 1, 2021

Study Completion

March 8, 2022

Last Updated

April 15, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations